tiprankstipranks
Poseida Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyPoseida Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
26d ago
Poseida downgraded to Market Perform from Outperform at William Blair
Premium
The Fly
Poseida downgraded to Market Perform from Outperform at William Blair
26d ago
Poseida Therapeutics downgraded to Neutral from Buy at BTIG
Premium
The Fly
Poseida Therapeutics downgraded to Neutral from Buy at BTIG
26d ago
Poseida Therapeutics Reports Strong Q3 2024 Progress
PremiumCompany AnnouncementsPoseida Therapeutics Reports Strong Q3 2024 Progress
1M ago
Poseida Therapeutics reports Q3 EPS 21c, consensus 41c
Premium
The Fly
Poseida Therapeutics reports Q3 EPS 21c, consensus 41c
1M ago
Poseida Therapeutics to present data on P-KLKB1-101 in hereditary angioedema
Premium
The Fly
Poseida Therapeutics to present data on P-KLKB1-101 in hereditary angioedema
2M ago
Poseida Therapeutics’ P-BCMA-101 shows efficacy in published case study
PremiumThe FlyPoseida Therapeutics’ P-BCMA-101 shows efficacy in published case study
4M ago
Poseida Therapeutics files $300M mixed securities shelf
Premium
The Fly
Poseida Therapeutics files $300M mixed securities shelf
5M ago
These 2 ‘Strong Buy’ Penny Stocks Could Rally to $10 (or More), Say Analysts
Premium
Stock Analysis & Ideas
These 2 ‘Strong Buy’ Penny Stocks Could Rally to $10 (or More), Say Analysts
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100